DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study (Q39332471)

11 September 2017

title

DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study (English)

1 reference

genome-wide association study

11 September 2017

main subject

0 references

Parkinson's disease

1 reference

inferred from title

parkinsonian syndrome

1 reference

1 reference

11 September 2017

Alexis Brice

0 references

Tatiana Foroud

object named as

Tatiana Foroud

0 references

Suzanne Lesage

object named as

Suzanne Lesage

1 reference

11 September 2017

Carles Vilariño-Güell

object named as

Carles Vilariño-Güell

1 reference

11 September 2017

Meriem Tazir

1 reference

11 September 2017

Jeanne Latourelle

1 reference

11 September 2017

Joanne Trinh

1 reference

11 September 2017

Emil K Gustavsson

1 reference

11 September 2017

Stephanie Bortnick

1 reference

11 September 2017

Marna B McKenzie

1 reference

11 September 2017

Chelsea Szu Tu

1 reference

11 September 2017

Ekaterina Nosova

1 reference

11 September 2017

Jaskaran Khinda

1 reference

11 September 2017

Austen Milnerwood

1 reference

11 September 2017

Jan O Aasly

1 reference

11 September 2017

Laura Parkkinen

1 reference

11 September 2017

Hazal Haytural

1 reference

11 September 2017

Richard H Myers

1 reference

11 September 2017

Samia Ben Sassi

1 reference

11 September 2017

Emna Hentati

1 reference

11 September 2017

Fatma Nabli

1 reference

11 September 2017

Emna Farhat

1 reference

11 September 2017

Rim Amouri

1 reference

11 September 2017

Fayçal Hentati

1 reference

11 September 2017

publication date

28 September 2016

1 reference

11 September 2017

1 reference

11 September 2017

1 reference

11 September 2017

1 reference

11 September 2017

page(s)

1248-1256

1 reference

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Low disease risk in relatives of north african lrrk2 Parkinson disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

LRRK2G2019S as a Cause of Parkinson's Disease in North African Arabs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Interplay of LRRK2 with chaperone-mediated autophagy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Genomewide linkage study of modifiers of LRRK2-related Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

PINK1 mutations and parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Merlin--rapid analysis of dense genetic maps using sparse gene flow trees

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

The role of SNCA and MAPT in Parkinson disease and LRRK2 parkinsonism in the Tunisian Arab-Berber population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

PLINK: a tool set for whole-genome association and population-based linkage analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Principal components analysis corrects for stratification in genome-wide association studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Imputation without doing imputation: a new method for the detection of non-genotyped causal variants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Haplotypic analysis of Wellcome Trust Case Control Consortium data

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Ordered subset analysis in genetic linkage mapping of complex traits

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

LRRK2 mutations in Parkinson's disease: confirmation of a gender effect in the Italian population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Differential distribution of dynamin isoforms in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

The familial Parkinsonism gene LRRK2 regulates neurite process morphology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Dynamin, a membrane-remodelling GTPase

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

A dynamin-3 spliced variant modulates the actin/cortactin-dependent morphogenesis of dendritic spines

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Upregulated dynamin 1 in an acute seizure model and in epileptic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2816%2930203-4

7 January 2021

10.1016/S1474-4422(16)30203-4

Identifiers

DOI

1 reference

11 September 2017

1 reference